Both ANXA5 and MMRN1 are considered biomarkers for GC diagnosis and progression68,73, while ANXA5 and MMP16 exhibit potential as predictive markers for lymph node and distant organ metastasis74,75. This evidence concerns the gene MMP16 and gastric cancer.